Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Third Candidate Using Cingulate. Real-time updates on events, politics, business and more.